Studies demonstrated that intensive insulin therapy could combat insulin resistance and decrease morbidity and mortality by modulating the proliferation, apoptosis, differentiation, and immune functions of certain immune cells, especially monocytes/macrophages, neutrophils, and T cells associated with sepsis (46). This evidence concerns the gene INS and Insulin resistance.